“The incidence of pancreatic cancer is increasing in men and in women under the age of 50. Previous studies have shown that patients with early-onset pancreatic cancer may do worse than those with later onset. Our study investigated factors impacting the observed differences in survival for patients diagnosed younger than age 50 versus those diagnosed at 50 and older,” said senior investigator Belinda Lee, MBBS, who presented the results at the 2022 ASCO Gastrointestinal Cancers Symposium. Read more . . .
Patients diagnosed with pancreatic cancer when they were younger than 50 years had improved survival compared with those diagnosed when they were 50 to 70 years of age, but not if there was metastatic disease at presentation, according to an analysis of an Australian pancreatic cancer registry.